Recent Company News

• 04:02 AM ET Jul 21, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 12:47 PM ET Jul 30, 2026
  

  Transcript Intelligence: Bachem Holding Q2 Earnings Guidance

• 12:47 PM ET Jul 30, 2026
  

  Transcript Intelligence: Bachem Holding Q2 Earnings Themes

• 12:47 PM ET Jul 30, 2026
  

  Transcript Intelligence: Bachem Holding Q2 Earnings Q&A

• 12:55 AM ET Jul 30, 2026
  

  Bachem Holding reports H1 EPS CHF0.67 vs FactSet CHF0.47 [4 est, CHF0.38-0.65] (CHF 73.60, 0.00)

• 07:02 AM ET Jul 21, 2026
  

  Tech, miners, banks and industrials the top gainers; defensives the main laggards:

• 02:58 AM ET Jul 21, 2026
  

  StreetAccount Summary - European pre-market trading update

• 02:39 AM ET Jul 21, 2026
  

  Bachem to invest more than CHF500M to build large-scale peptide production facility in Sisslerfeld (CHF 70.25, 0.00)

• 02:14 AM ET Jun 25, 2026
  

  ImmuPharma appoints Bachem as API manufacturing partner for Kapiglucagon (4.0000p, 0)